ATPase Inhibitory Factor 1 Promotes Hepatocellular Carcinoma Progression After Insufficient Radiofrequency Ablation, and Attenuates Cell Sensitivity to Sorafenib Therapy

Epithelial-mesenchymal transition (EMT) and angiogenesis is involved in tumor progression after radiofrequency ablation (RFA). ATPase inhibitory factor 1 (IF1) is a bad predictor of prognosis. Sorafenib inhibited EMT of hepatocellular carcinoma (HCC) after RFA. Whether IF1 promotes the EMT and angio...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Jian, Yao, Changyu, Ding, Xuemei, Dong, Shuying, Wu, Shilun, Sun, Wenbing, Zheng, Lemin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330926/
https://www.ncbi.nlm.nih.gov/pubmed/32670888
http://dx.doi.org/10.3389/fonc.2020.01080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330926/
https://www.ncbi.nlm.nih.gov/pubmed/32670888
http://dx.doi.org/10.3389/fonc.2020.01080

Ejemplares similares